WEBINAR
Breast tumor cryoablation with the ProSense System:
ICE3 Study Update
Dr. Richard E. Fine, MD, FACS presents the technology and techniques behind breast tumor cryoablation using the liquid nitrogen (LN2) based ProSense System. In this webinar, Dr. Fine presents an in-depth look at the positive interim results of the landmark ICE3 clinical trial on cryoablation of small, low-risk breast cancers.
CONTACT US
Headquarters
IceCure Medical Ltd
7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504 Israel
T +972-4-623-0333
E info@icecure-medical.com
USA
IceCure Medical Inc
T +1-888-902-5716
E icecuresupport@icecure-medical.com